Internal Medical Department, Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan (250011), China.
Chin J Integr Med. 2010 Apr;16(2):138-44. doi: 10.1007/s11655-010-0138-4. Epub 2010 May 16.
To observe the difference in fatty degree, glucose-lipid disorder and adipose-hormones between diet induced obesity (DIO) rats and diet induced obesity resistance (DIO-R) rats, and to explore the effect and acting mechanism of Chinese drugs for strengthening Pi (CD-SP) and those for both strengthening Pi and dissolving phlegm (CD-SPDP) in inhibiting obesity.
Excepting eight rats allocated in the blank control group, the other 54 rats were fed with high-lipid forage for 12 weeks to establish models of obesity. Finally, 30 DIO rats and 8 DIO-R rats (shown by their body weight) were obtained. The DIO rats were divided into three groups, which were given gastric perfusion, respectively, with normal saline (Group A), CD-SP (Group B), and CD-SPDP (Group C). Fourteen weeks later, the animals' body weight (BW), length (BL), blood levels of fasting insulin (FIn), fasting glucose (FBG), triglyceride (TG), cholesterol (TC), leptin (LP), neuropeptide Y (NPY), C-reactive protein (CRP), tumor necrosis factor-alpha(TNF-alpha), adiponectin (AN), and resistin (RS) were measured; insulin resistance index (IRI) was calculated, and the degree of obesity and lipid content in abdominal cavity of rats were estimated. Moreover, the levels of LP, CRP, TNF-alpha, AN and RS in homogenate of rats' adipose tissues (ATH) were determined.
After 12 weeks of high-lipid diet, the BW of DIO rats was higher than that of normal or DIO-R rats. After a 14-week continuous high-lipid diet feeding, in DIO rats, BW, lipid coefficient (LC), and IRI were significantly increased (P<0.01); serum levels of TNF-alpha, LP and AN were lower, NPY was higher, while the ATH levels of LP and AN were lower and TNF-alpha was higher in DIO rats than in DIO-R rats (P<0.05 or P<0.01); blood levels of FBG and lipids in DIO rats showed an increasing trend but was statistically insignificant (P>0.05); no significant difference was found in serum levels of CRP and RS due to the overly high data dispersion. Comparisons of the 3 DIO groups showed that BW, body weight index (BWI), LC and IRI were significantly lowered after treatment (P<0.01) in Group C, while these indexes were not significantly different between Group A and B; the serum levels of TNF-alpha, LP, and AN increased, NPY decreased in Group B and C, ATH levels of LP and AN increased, and TNF-alpha decreased in the two groups; but NPY, LP, and AN in blood and ATH were higher in Group C than those in Group B (P<0.05 or P<0.01).
CD-SPDP could inhibit DIO and IR, showing that the effect is better than that of CD-SP, and its mechanism is related to promotion of LP and AN secretion and elevation of serum NPY.
观察饮食诱导肥胖(DIO)大鼠和饮食诱导肥胖抵抗(DIO-R)大鼠在脂肪程度、糖脂紊乱和脂肪激素方面的差异,探讨中药健脾化痰方(CD-SP)和健脾化痰方(CD-SPDP)抑制肥胖的作用及作用机制。
除空白对照组 8 只大鼠外,其余 54 只大鼠给予高脂饲料喂养 12 周,建立肥胖模型。最后获得 30 只 DIO 大鼠和 8 只 DIO-R 大鼠(以体重表示)。DIO 大鼠分为三组,分别给予生理盐水(A 组)、CD-SP(B 组)和 CD-SPDP(C 组)灌胃。14 周后,测量大鼠体重(BW)、体长(BL)、空腹胰岛素(FIn)、空腹血糖(FBG)、甘油三酯(TG)、胆固醇(TC)、瘦素(LP)、神经肽 Y(NPY)、C 反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、脂联素(AN)和抵抗素(RS)水平;计算胰岛素抵抗指数(IRI),并估计大鼠肥胖程度和腹腔脂肪含量。此外,还测定了大鼠脂肪组织匀浆(ATH)中 LP、CRP、TNF-α、AN 和 RS 的水平。
高脂饮食 12 周后,DIO 大鼠 BW 高于正常大鼠和 DIO-R 大鼠。经过 14 周的持续高脂饮食喂养,DIO 大鼠 BW、脂系数(LC)和 IRI 显著升高(P<0.01);血清 TNF-α、LP 和 AN 水平降低,NPY 水平升高,而 DIO 大鼠 LP 和 AN 的 ATH 水平降低,TNF-α水平升高(P<0.05 或 P<0.01);DIO 大鼠 FBG 和血脂水平呈上升趋势,但无统计学意义(P>0.05);由于数据分散过高,血清 CRP 和 RS 水平无显著差异。3 组 DIO 大鼠比较显示,C 组治疗后 BW、体重指数(BWI)、LC 和 IRI 明显降低(P<0.01),而 A 组和 B 组之间无显著差异;B 组和 C 组血清 TNF-α、LP 和 AN 水平升高,NPY 水平降低,两组 LP 和 AN 的 ATH 水平升高,TNF-α水平降低;但 C 组的血清 NPY、LP 和 AN 以及 ATH 高于 B 组(P<0.05 或 P<0.01)。
CD-SPDP 可抑制 DIO 和 IR,作用优于 CD-SP,其机制与促进 LP 和 AN 分泌及升高血清 NPY 有关。